Related Experiment Video
Updated: Oct 7, 2025

Circumscribed Capsular Infarct Modeling Using a Photothrombotic Technique
Published on: June 2, 2016
Isolated thrombosis after COVID-19 vaccination: case series
Mona Al-Ahmad1,2, Mona Al Rasheed3, Lulwa Altourah3
1Microbiology Department, Faculty of Medicine, Kuwait University, P.O. Box 24923, 13110, Safat, Kuwait. mona.alahmad@ku.edu.kw.
Background:
Data regarding thrombosis after COVID-19 vaccination are scarce.
Methods:
Clinical and laboratory data were collected from all patients who developed thrombosis within 4 weeks of receiving the Pfizer or Oxford/AstraZeneca vaccine. None had a COVID-19-positive swab.
Results:
Seventeen patients were included, with average age of 48.8 years and equal proportion of females to males. Our data suggest that thrombosis occurred in 1 in 163,000 of all individuals who had received any dose of any type of COVID-19 vaccine: six (1 in 123,000) patients after the first dose of Oxford/AstraZeneca, none after the second dose of Oxford/AstraZeneca, four (1 in 257,000) patients after the first dose of the Pfizer vaccine, and seven (1 in 102,000) patients after the second dose of Pfizer vaccine. Three of 17 patients with thrombosis (17.6%) died.
Conclusions:
We believe this report to be one of the earliest in the literature to address the question of whether isolated thrombosis is a possible complication of COVID-19 vaccination.
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis I: Introduction
Venous Thrombosis IV: Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism I: Introduction

